5HC-38902-16112

3 vaccinations 9 coded responses 15 check-ins 9 free-text entries 4 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 197 / DE
Registered: 2021-11-09

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-16
Dose 1 — Pfizer-BioNTech
2021-05-07
Dose 2 — Pfizer-BioNTech
2021-11-09
Registered in v-safe
2021-11-09
Dose 3 — Pfizer-BioNTech
2021-11-09
Health check-in — day 0, dose 3
Feeling: Good · Site: Itching · Diarrhea

Adult check-in
2021-11-11
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-11-12
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Diarrhea · Be unable to do your normal daily activities

Free text: Swollen lymph nodes under arm.

MedDRA releases: 2024-11 · check-in free text available
2021-11-13
Survey response — days 1–6 daily, dose 3
MedDRA: Migraine — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: The headache is a migraine

MedDRA releases: 2024-11 · check-in free text available
2021-11-14
Survey response — days 1–6 daily, dose 3
MedDRA: Arthritis reactive — Feeling: Poor · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Free text: Reactive Arthritis

MedDRA releases: 2024-11 · check-in free text available
2021-11-15
Survey response — days 1–6 daily, dose 3
MedDRA: Arthritis reactive — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Free text: Reactive Arthritis

MedDRA releases: 2024-11 · check-in free text available
2021-11-16
Survey response — day 7, dose 3
MedDRA: Erythema, Groin pain, Inflammation — Feeling: Fair · Joint pains, Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: My groin is entirely inflamed. It was fine when I went to bed and woke up, it's bright red and very sore.

MedDRA releases: 2024-11 · check-in free text available
2021-11-16
Report sent to call center — day 7, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-11-17
Call 2 — Left Voicemail
2021-11-23
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-24
Call successful
Completed over the phone
2021-11-30
Survey response — day 21, dose 3
MedDRA: Fatigue, Muscular weakness — Feeling: Poor · Be unable to do your normal daily activities

Free text: Extreme fatigue and muscle weakness.

MedDRA releases: 2024-11 · check-in free text available
2021-12-07
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-12-14
Survey response — day 35, dose 3
MedDRA: Myalgia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Extreme muscle pain. It feels as though the muscle will detach from the bone. · Healthcare visit (other): I have an appointment Tuesday, Dec 21st

MedDRA releases: 2024-11 · check-in free text available
2021-12-14
Report sent to call center — day 35, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-12-16
Call successful
Reported to VAERS during previous contact from GDIT
2021-12-21
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-02-08
Survey response — 3 months, dose 3
MedDRA: Muscle swelling, Muscular weakness, Myalgia, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: Intense, pervasive muscle pain/swelling/weakness. Possibly have an autoimmune disorder. · Healthcare visit (other): Will be seeing rheumatologist

MedDRA releases: 2024-11 · check-in free text available
2022-02-08
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-09
Call successful
Reported to VAERS during previous contact from GDIT
2022-05-10
Survey response — 6 months, dose 3
MedDRA: Migraine, Musculoskeletal stiffness — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Severe migraine with neck stiffness

MedDRA releases: 2024-11 · check-in free text available
2022-05-10
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-05-11
Call 1 — Left Voicemail
2022-05-11
Call 1 — Left Voicemail
2022-05-11
Call 1 — Left Voicemail
2022-05-11
Call 1 — Left Voicemail
2022-11-09
Health check-in — 12 months, dose 3
Feeling: Poor

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-16	Pfizer-BioNTech	No
2	2021-05-07	Pfizer-BioNTech	No
3	2021-11-09	Pfizer-BioNTech	No

Call center

4 call center cases

3 successful · 1 unsuccessful

VAERS report filed, before or during a call: 3

2 waits over 3 months for a first call

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-11-12

Systemic reaction (other): Swollen lymph nodes under arm.

2021-11-13

Systemic reaction (other): The headache is a migraine

2021-11-14

Systemic reaction (other): Reactive Arthritis

2021-11-15

Systemic reaction (other): Reactive Arthritis

Release 10 — day 7, dose 3

2021-11-16

Systemic reaction (other): My groin is entirely inflamed. It was fine when I went to bed and woke up, it's bright red and very sore.

Release 10 — day 21, dose 3

2021-11-30

Symptoms: Extreme fatigue and muscle weakness.

Release 10 — day 35, dose 3

2021-12-14

Symptoms: Extreme muscle pain. It feels as though the muscle will detach from the bone.

Healthcare visit (other): I have an appointment Tuesday, Dec 21st

Release 11 — 3 months, dose 3

2022-02-08

Symptoms: Intense, pervasive muscle pain/swelling/weakness. Possibly have an autoimmune disorder.

Healthcare visit (other): Will be seeing rheumatologist

Release 11 — 6 months, dose 3

2022-05-10

Symptoms: Severe migraine with neck stiffness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Fatigue	·	·	✓
SD	Migraine	·	·	✓
SD	Muscle swelling	·	·	✓
SD	Muscular weakness	·	·	✓
SD	Musculoskeletal stiffness	·	·	✓
SD	Myalgia	·	·	✓
SRO	Arthritis reactive	·	·	✓
SRO	Erythema	·	·	✓
SRO	Groin pain	·	·	✓
SRO	Inflammation	·	·	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Migraine	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release